Literature DB >> 19560486

Anthrax toxins: a weapon to systematically dismantle the host immune defenses.

Jean-Nicolas Tournier1, Silvia Rossi Paccani, Anne Quesnel-Hellmann, Cosima T Baldari.   

Abstract

Successful colonization of the host by bacterial pathogens relies on their capacity to evade the complex and powerful defenses opposed by the host immune system, at least in the initial phases of infection. The two toxins of Bacillus anthracis, lethal toxin and edema toxin, appear to have been shaped by evolution to assist the microorganism in this crucial function, in addition to act as general toxins acting on almost all cell types. Edema toxin causes a consistent elevation of cAMP, an important second messenger the production of which is normally strictly controlled in mammalian cells, whereas lethal toxin cleaves most isoforms of mitogen-activated protein kinase kinases. By disrupting or subverting central modules common to all the principal signaling networks which control immune cell activation, effector function and migration, the anthrax toxins effectively and systematically dismantle both the innate and the adaptive immune defenses of the host. Here, we review the specific effects of the lethal and edema toxins of B. anthracis on the activation and function of phagocytes, dendritic cells and lymphocytes. We also discuss some open issues which should be addressed to gain a comprehensive insight into the complex relationship that B. anthracis establishes with the host.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19560486     DOI: 10.1016/j.mam.2009.06.002

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  69 in total

Review 1.  New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.

Authors:  Annabel Guichard; Victor Nizet; Ethan Bier
Journal:  Microbes Infect       Date:  2011-09-08       Impact factor: 2.700

2.  Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice.

Authors:  Shihui Liu; Sharmina Miller-Randolph; Devorah Crown; Mahtab Moayeri; Inka Sastalla; Shu Okugawa; Stephen H Leppla
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

3.  Binding of filamentous actin to anthrax toxin receptor 1 decreases its association with protective antigen.

Authors:  Kristopher M Garlick; Sarah Batty; Jeremy Mogridge
Journal:  Biochemistry       Date:  2012-02-03       Impact factor: 3.162

Review 4.  Anthrax lethal and edema toxins in anthrax pathogenesis.

Authors:  Shihui Liu; Mahtab Moayeri; Stephen H Leppla
Journal:  Trends Microbiol       Date:  2014-03-27       Impact factor: 17.079

5.  Micropatterned macrophage analysis reveals global cytoskeleton constraints induced by Bacillus anthracis edema toxin.

Authors:  Yannick Trescos; Emilie Tessier; Clémence Rougeaux; Pierre L Goossens; Jean-Nicolas Tournier
Journal:  Infect Immun       Date:  2015-05-26       Impact factor: 3.441

6.  Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated.

Authors:  Eric K Dumas; Lori Garman; Hannah Cuthbertson; Sue Charlton; Bassam Hallis; Renata J M Engler; Shyamal Choudhari; William D Picking; Judith A James; A Darise Farris
Journal:  Vaccine       Date:  2017-05-11       Impact factor: 3.641

Review 7.  The Bacillus cereus Group: Bacillus Species with Pathogenic Potential.

Authors:  Monika Ehling-Schulz; Didier Lereclus; Theresa M Koehler
Journal:  Microbiol Spectr       Date:  2019-05

Review 8.  New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.

Authors:  J M Beierlein; A C Anderson
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

9.  Deterministic models of inhalational anthrax in New Zealand white rabbits.

Authors:  Bradford Gutting
Journal:  Biosecur Bioterror       Date:  2014-02-14

10.  Novel role for the yceGH tellurite resistance genes in the pathogenesis of Bacillus anthracis.

Authors:  Sarah E Franks; Celia Ebrahimi; Andrew Hollands; Cheryl Y Okumura; Raffi V Aroian; Victor Nizet; Shauna M McGillivray
Journal:  Infect Immun       Date:  2013-12-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.